Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_16-cv-02788/USCOURTS-cand-3_16-cv-02788-26/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:145 Patent Infringement

---

Farella Braun + Martel LLP 

235 Montgomery Street, 17th Floor

San Francisco, CA 94104 

(415) 954-4400 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

STIP/ORDER RE PATENT DISCLOSURES, 

CLAIM CONSTRUCTION; Case No. 16-cv-02788-

WHA

33250\5478349.1

John L. Cooper (SBN 50324)

 jcooper@fbm.com 

Jeffrey M. Fisher (SBN 155284) 

 jfisher@fbm.com 

Winston Liaw (State Bar No. 273899) 

 wliaw@fbm.com 

FARELLA BRAUN & MARTEL LLP 

235 Montgomery Street, 17th Floor 

San Francisco, California 94104 

Telephone: (415) 954-4400 

Facsimile: (415) 954-4480 

Robert R. Baron, Jr. (PA SBN 67084) 

(appearance pro hac vice) 

 baron@ballardspahr.com 

Marc S. Segal (PA SBN 84474) 

(appearance pro hac vice) 

 segalm@ballardspahr.com 

Tyler R. Marandola (PA SBN 313585) 

(appearance pro hac vice) 

 marandolat@ballardspahr.com 

BALLARD SPAHR LLP 

1735 Market Street, 51st Floor 

Philadelphia, PA 19103-7599 

Telephone: (215) 665-8500 

Facsimile: (215) 864-8999 

Attorneys for Defendants QIAGEN, N.V., 

QIAGEN GmbH, QIAGEN Gaithersburg, Inc.,

QIAGEN Sciences, LLC, QIAGEN Inc. (USA),

QIAGEN Redwood City, Inc., and 

Intelligent Bio-Systems, Inc. 

Edward R. Reines (SBN 135960)

 edward.reines@weil.com 

Derek C. Walter (SBN 246322) 

 derek.walter@weil.com 

WEIL, GOTSHAL & MANGES LLP 

201 Redwood Shores Parkway 

Redwood Shores, California 94065 

Telephone: (650) 802-3000 

Facsimile: (650) 802-3100 

Attorneys for Plaintiffs Illumina, Inc. and

Illumina Cambridge Ltd.

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

ILLUMINA, INC.

ILLUMINA CAMBRIDGE LTD., 

Plaintiffs, 

vs. 

QIAGEN N.V., QIAGEN GmbH, 

QIAGEN GAITHERSBURG, INC., 

QIAGEN SCIENCES, LLC, 

QIAGEN INC. (USA), QIAGEN 

REDWOOD CITY, INC., and 

INTELLIGENT BIO-SYSTEMS, INC., 

Defendants. 

Case No. 16-cv-02788-WHA

STIPULATION AND [PROPOSED] 

ORDER REGARDING PATENT 

DISCLOSURES AND CLAIM 

CONSTRUCTION 

Case 3:16-cv-02788-WHA Document 165 Filed 12/13/16 Page 1 of 3
Farella Braun + Martel LLP 

235 Montgomery Street, 17th Floor

San Francisco, CA 94104 

(415) 954-4400 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

STIP/ORDER RE PATENT DISCLOSURES, 

CLAIM CONSTRUCTION; Case No. 16-cv-02788-

WHA

- 2 - 33250\5478349.1

WHEREAS, on May 24, 2016, Illumina, Inc. and Illumina Cambridge Ltd. (collectively, 

“Illumina”) filed its Complaint [Dkt. No. 1] against defendants QIAGEN N.V., QIAGEN GmbH, 

QIAGEN Gaithersburg, Inc., QIAGEN Sciences, LLC, QIAGEN Inc. (USA), QIAGEN Redwood 

City, Inc., and Intelligent Bio-Systems, Inc. (collectively, “QIAGEN”) asserting U.S. Patent No. 

7,566,537 (“the ’537 Patent”); 

WHEREAS, on November 29, 2016, the Court granted Plaintiffs Illumina Inc., and 

Illumina Cambridge Ltd.’s (collectively “Illumina”) motion to supplement its complaint to assert 

claims for infringement of U.S. Patent No. 9,410,200 (“the ’200 Patent”) [Dkt. No. 162]; 

WHEREAS, the parties believe that it will be most efficient to synchronize the patent 

disclosures and claim construction proceedings for both the ’537 and ’200 Patents; 

NOW THEREFORE, the parties HEREBY STIPULATE AND AGREE, subject to the 

approval and order of the Court, to the following amended schedule for the patent disclosures and 

claim construction proceedings: 

NOW THEREFORE, the parties HEREBY STIPULATE AND AGREE, subject to the 

approval and order of the Court, to the following schedule for the completion of the patent 

disclosures and claim construction proceedings: 

1. Illumina will serve supplemental infringement contentions that include allegations 

regarding the ’200 Patent under Patent L.R. 3-1 and 3-2 on December 16, 2016. 

2. QIAGEN will serve supplemental invalidity contentions that include allegations 

regarding the ’200 Patent under Patent L.R. 3-4 and 3-5 on January 6, 2017. 

3. The parties will exchange an updated, supplemental list of proposed claim terms 

for construction that include terms from both the ’537 and ’200 Patents under Patent L.R. 4-1 on 

January 13, 2017. 

4. The parties will exchange proposed preliminary claim constructions for both the 

’537 and ’200 Patents under Patent L.R. 4-2 on January 20, 2017. 

5. The parties shall file a Joint Claim Construction and Prehearing Statement under 

Patent L.R. 4-3 on February 3, 2017. 

Case 3:16-cv-02788-WHA Document 165 Filed 12/13/16 Page 2 of 3
Farella Braun + Martel LLP 

235 Montgomery Street, 17th Floor

San Francisco, CA 94104 

(415) 954-4400 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

STIP/ORDER RE PATENT DISCLOSURES, 

CLAIM CONSTRUCTION; Case No. 16-cv-02788-

WHA

- 3 - 33250\5478349.1

6. The completion of claim construction briefing will be according to schedule under 

Patent L.R. 4-5. 

IT IS SO STIPULATED. 

Dated: December 12, 2016

I, John L. Cooper, represent that 

concurrence in the filing of this 

document has been obtained from 

the other signatory, which shall 

serve in lieu of his signature on this 

document. 

FARELLA BRAUN & MARTEL LLP

/s/ John L. Cooper

John L. Cooper

Attorneys For Defendants 

QIAGEN, N.V., QIAGEN GMBH, QIAGEN 

GAITHERSBURG, INC., QIAGEN SCIENCES, 

LLC, QIAGEN INC. (USA), QIAGEN 

REDWOOD CITY, INC., AND INTELLIGENT 

BIO-SYSTEMS, INC.

WEIL, GOTSHAL & MANGES LLP

/s/ Edward R. Reines

Edward R. Reines

Attorneys for Plaintiffs

ILLUMINA, INC. AND ILLUMINA 

CAMBRIDGE LTD.

[PROPOSED] ORDER 

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

IT IS SO ORDERED. 

Dated: ___________________ 

HON. WILLIAM ALSUP 

UNITED STATES DISTRICT JUDGE 

Case 3:16-cv-02788-WHA Document 165 Filed 12/13/16 Page 3 of 3